Skip to Content

Medtronic’s MiniMed board sees shake up

Medtronic’s MiniMed board sees shake up

NORTHRIDGE, Calif. – Brett Wall, a class II director of MiniMed Group’s board of directors, has resigned following his departure as executive vice president and president of the neurosciences portfolio of Medtronic, the parent company of MiniMed, according to a Securities and Exchange Commission (SEC) filing. Wall, who was also a member of the board’s Nominating and Corporate Governance Committee, was nominated to the MiniMed board by Medtronic. Scott Cundy will fill his vacancy on the MiniMed board effective July 3. Cundy serves as senior vice president and chief quality, development and innovation officer at Medtronic, leading the company’s global quality, product development and innovation functions. He is also a member of Medtronic’s Executive Committee. In March, MiniMed began trading on the Nasdaq under the ticker symbol “MMED” in connection with its initial public offering (IPO).

Comments

To comment on this post, please log in to your account or set up an account now.